| pubmed-article:3266681 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3266681 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:3266681 | lifeskim:mentions | umls-concept:C0030520 | lld:lifeskim |
| pubmed-article:3266681 | lifeskim:mentions | umls-concept:C0035435 | lld:lifeskim |
| pubmed-article:3266681 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:3266681 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3266681 | pubmed:dateCreated | 1989-6-2 | lld:pubmed |
| pubmed-article:3266681 | pubmed:abstractText | The mechanism of joint destruction in rheumatic diseases is a complex and not fully known phenomenon in which many factors probably take part. The hormones which regulate the bone metabolism may be engaged in this process. In this study the serum level of the parathyroid hormone was correlated with the degree of joint destruction observed in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Besides the degree of joint changes (radiologic aspects) the extension of the pathological process and duration of disease were also considered and the serum and urine level of calcium and phosphorus was analyzed. Similar patterns of the parameter investigated were observed in the rheumatic diseases studied and in healthy persons. | lld:pubmed |
| pubmed-article:3266681 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3266681 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3266681 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3266681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3266681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3266681 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3266681 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3266681 | pubmed:issn | 0377-1202 | lld:pubmed |
| pubmed-article:3266681 | pubmed:author | pubmed-author:LewandowskiBB | lld:pubmed |
| pubmed-article:3266681 | pubmed:author | pubmed-author:SierakowskiSS | lld:pubmed |
| pubmed-article:3266681 | pubmed:author | pubmed-author:BernackaKK | lld:pubmed |
| pubmed-article:3266681 | pubmed:author | pubmed-author:TytmanKK | lld:pubmed |
| pubmed-article:3266681 | pubmed:author | pubmed-author:PolakowJJ | lld:pubmed |
| pubmed-article:3266681 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3266681 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:3266681 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3266681 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3266681 | pubmed:pagination | 273-8 | lld:pubmed |
| pubmed-article:3266681 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:meshHeading | pubmed-meshheading:3266681-... | lld:pubmed |
| pubmed-article:3266681 | pubmed:articleTitle | Serum level of parathyroid hormone in certain rheumatic diseases. | lld:pubmed |
| pubmed-article:3266681 | pubmed:affiliation | Department of Rheumatology, Medical Academy Hospital, Bialystok, Poland. | lld:pubmed |
| pubmed-article:3266681 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3266681 | pubmed:publicationType | Comparative Study | lld:pubmed |
